Reunion Neuroscience Stock Target Price

Summary

REUNDelisted Stock

USD 1.12 0.01 0.90%

Reunion Neuroscience fundamentals help investors to digest information that contributes to Reunion Neuroscience's financial success or failures. It also enables traders to predict the movement of Reunion Stock. The fundamental analysis module provides a way to measure Reunion Neuroscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reunion Neuroscience stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Reunion Target Price Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reunion Neuroscience's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Reunion Neuroscience could also be used in its relative valuation, which is a method of valuing Reunion Neuroscience by comparing valuation metrics of similar companies.

Reunion Neuroscience is currently under evaluation in target price category among its peers.

Reunion Fundamentals

	Return On Equity	-0.86
	Return On Asset	-0.27
	Current Valuation	(13.96 M)
	Shares Outstanding	11.72 M
	Shares Owned By Insiders	34.39 %
	Shares Owned By Institutions	50.65 %
	Number Of Shares Shorted	114.9 K
	Price To Book	0.49 X
	Price To Sales	2.80 X
	Gross Profit	(4.29 M)
	EBITDA	(17.15 M)
	Net Income	(48.49 M)
	Cash And Equivalents	48.13 M
	Cash Per Share	4.14 X
	Total Debt	3.37 M
	Current Ratio	47.74 X
	Book Value Per Share	1.82 X
	Cash Flow From Operations	(27.92 M)
	Short Ratio	1.92 X
	Earnings Per Share	(2.51) X
	Target Price	9.39
	Number Of Employees	16
	Beta	4.21
	Market Capitalization	13.01 M
	Total Asset	29.74 M
	Retained Earnings	(91.48 M)
	Working Capital	21.24 M
	Z Score	-3.04
	Net Asset	29.74 M

About Reunion Neuroscience Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Reunion Neuroscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reunion Neuroscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reunion Neuroscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Reunion Neuroscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Reunion Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reunion Neuroscience will appreciate offsetting losses from the drop in the long position's value.

Moving against Reunion Stock

0.78	NVO	Novo Nordisk AS	Pair Corr
0.78	REGN	Regeneron Pharmaceuticals	Pair Corr
0.77	NONOF	Novo Nordisk AS	Pair Corr
0.71	QSAM	Qsam Biosciences	Pair Corr
0.66	EPGG	Empire Global Gaming	Pair Corr

The ability to find closely correlated positions to Reunion Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Reunion Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Reunion Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Reunion Neuroscience to buy it.

The correlation of Reunion Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reunion Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reunion Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Reunion Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in Reunion Stock

If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.

	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Global Correlations Find global opportunities by holding instruments from different markets
	Commodity Directory Find actively traded commodities issued by global exchanges
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC